Management of the pregnant inflammatory bowel disease patient on antitumour necrosis factor therapy: State of the art and future directions

Antitumour necrosis factor (anti-TNF) therapy has been a major advance in the treatment of inflammatory bowel disease (IBD) by improving rates of mucosal healing, steroid-free remission, and decreasing rates of hospitalization and surgery. Because IBD affects women in their reproductive years, clini...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Leung, Yvette PY, Panaccione, Remo, Ghosh, Subrata, Seow, Cynthia H
Formato: Artigo
Lenguaje:Inglês
Publicado: Pulsus Group Inc 2014
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4205908/
https://ncbi.nlm.nih.gov/pubmed/25101334
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares